US Stocks
/
Rezolute, Inc.  (NV) Share Price

Rezolute, Inc. (NV) Share Price

NASDAQ: RZLT | Small Cap
$4.67
-$0.02 (-0.43%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Rezolute, Inc. (NV) Stock Performance

Open
$4.78
Prev. Close
$4.70
Circuit Range
N/A
Day Range
$4.54 - $4.78
Year Range
$1.07 - $11.43
Volume
62,968
Average Traded
$4.61

Rezolute, Inc. (NV) Share Price Today

As of 10 August 2026, Rezolute, Inc. (NV)'s share price is $4.67. The stock opened at $4.78, compared to its previous close of $4.70. During today's trading session, Rezolute, Inc. (NV)'s share price traded between $4.54 and $4.78, with an average price of $4.66. Over the past 52 weeks, the stock has recorded a high of $11.43 and a low of $1.07. In terms of performance, Rezolute, Inc. (NV)'s share price has risen by 45.64% over the last six months and is down 34.29% on a year-on-year basis.

Rezolute, Inc. (NV) Share Price Chart

$4.54$4.78
L
Show Current Price
H

Rezolute, Inc. (NV) Stock Fundamentals & Key Indicators

Market Cap
$355.30M
PE Ratio (TTM)
-4.77
Dividend Yield
N/A
EPS (TTM)
$-0.98
Revenue (TTM)
N/A
Return On Equity (TTM)
-45.90%
Profit Margin
N/A
Debt to Equity
0.07
Quarterly Earnings Growth YoY
-44.78%

Rezolute, Inc. (NV) Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Sep 2024Dec 2024Mar 2025Sep 2025Dec 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$17.05M-$15.38M-$15.73M-$18.91M-$18.15M-$22.77M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A9.81%-2.29%-20.24%4.04%-25.48%

Rezolute, Inc. (NV) Annual Profit & Loss

All figures in USD

Particulars2022202320242025
RevenueN/AN/AN/AN/A
Net Profit-$41.06M-$51.79M-$68.46M-$74.41M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-26.13%-32.19%-8.70%

About Rezolute, Inc. (NV)

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.

Rezolute, Inc. (NV) Historical Returns

MonthOpenCloseChange %
Aug 2026
$4.60
$4.67
-1.16%
Jul 2026
$5.28
$4.73
-8.95%
Jun 2026
$3.27
$5.20
+56.95%
May 2026
$3.17
$3.31
+3.44%
Apr 2026
$3.14
$3.20
+5.26%
Mar 2026
$3.04
$3.04
-5.30%
Feb 2026
$3.28
$3.21
-3.75%
Jan 2026
$2.34
$3.33
+41.01%
Dec 2025
$9.58
$2.37
-75.63%
Nov 2025
$9.19
$9.71
+3.96%
Oct 2025
$9.47
$9.34
-0.74%
Sep 2025
$7.15
$9.40
+32.19%

RZLT Share Price FAQs

What is Rezolute, Inc. (NV) share price today?

chevron-up
Rezolute, Inc. (NV) share price today is $4.67 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Rezolute, Inc. (NV) stock?

chevron-up
The 52 week high of Rezolute, Inc. (NV) stock is $11.43, while the 52 week low is $1.07 as of 8 Aug '26.

What is RZLT's market capitalisation today?

chevron-up
RZLT market capitalisation is $355.30M as of August 10, 2026, at 12:10 pm IST.

What is RZLT's net income for the last quarter?

chevron-up
RZLT's net income for the last quarter is -0.02B USD.

What is the 5 year returns of RZLT?

chevron-up
The 5 year returns of RZLT is -49.40% as on 8 Aug '26.

What is the high & low stock price of RZLT today?

chevron-up
RZLT stock price hit a high of $4.78 and low of $4.54 as of 8 Aug '26.

Can I buy RZLT shares in India?

chevron-up
Yes. You can buy RZLT in India by opening an international trading account.